We provide you with 20 years of free, institutional-grade data for TEVA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TEVA. Explore the full financial landscape of TEVA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$18,880,463
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Shields Matthew | Sale | -9,989 | $32.19 | $321,547 | 2026-06-22 |
| Kalif Eliyahu Sharon | Sale | -106,563 | $34.1 | $3,633,308 | 2026-06-16 |
| BARER SOL J | Derivatives Exercise | 21,739 | 2026-06-08 | ||
| Lichtenstein Chen | Derivatives Exercise | 14,492 | 2026-06-08 | ||
| Crane Rosemary A | Derivatives Exercise | 14,492 | 2026-06-08 | ||
| Elstein Amir | Derivatives Exercise | 14,492 | 2026-06-08 | ||
| LIEBERMAN GERALD M | Derivatives Exercise | 14,492 | 2026-06-08 | ||
| Nisen Perry | Derivatives Exercise | 14,492 | 2026-06-08 | ||
| Satchi-Fainaro Ronit | Derivatives Exercise | 14,492 | 2026-06-08 | ||
| Zaks Tal Zvi | Derivatives Exercise | 14,492 | 2026-06-08 | ||
| MIGNONE ROBERTO | Derivatives Exercise | 14,492 | 2026-06-08 | ||
| Francis Richard D | Sale | -6,153 | $34.35 | $211,356 | 2026-06-08 |
| Francis Richard D | Derivatives Exercise | 13,043 | 2026-06-08 | ||
| Shields Matthew | Sale | -16,195 | $32.87 | $532,330 | 2026-06-04 |
| Shields Matthew | Derivatives Exercise | 16,195 | 2026-06-04 | ||
| Kalif Eliyahu Sharon | Sale | -153,251 | $35.61 | $5,457,375 | 2026-05-18 |
| Lippman Evan | Sale | -41,658 | $35.58 | $1,482,367 | 2026-05-18 |
| Lippman Evan | Derivatives Exercise | 85,849 | 2026-05-18 | ||
| Daniell Richard | Sale | -30,000 | $35.4 | $1,062,000 | 2026-05-07 |
| Weiss Amir | Sale | -10,679 | $36 | $384,444 | 2026-05-07 |
| Sabag Mark | Sale | -144,180 | $34.99 | $5,045,118 | 2026-05-04 |
| Fox Christine | Sale | -21,258 | $35.31 | $750,620 | 2026-05-04 |
| Sabag Mark | Sale | -62,102 | $30.14 | $1,871,816 | 2026-03-19 |
| Sabag Mark | Derivatives Exercise | 15,723 | 2026-03-09 | ||
| Kalif Eliyahu Sharon | Derivatives Exercise | 19,916 | 2026-03-09 | ||
| Weiss Amir | Derivatives Exercise | 3,537 | 2026-03-09 | ||
| Francis Richard D | Sale | -20,025 | $31.67 | $634,160 | 2026-03-09 |
| Francis Richard D | Derivatives Exercise | 42,452 | 2026-03-09 | ||
| Fox Christine | Sale | -7,924 | $31.67 | $250,940 | 2026-03-09 |
| Fox Christine | Derivatives Exercise | 17,819 | 2026-03-09 | ||
| Hughes Eric A | Sale | -9,533 | $31.67 | $301,895 | 2026-03-09 |
| Hughes Eric A | Derivatives Exercise | 19,654 | 2026-03-09 | ||
| Daniell Richard | Sale | -17,295 | $31.67 | $547,705 | 2026-03-09 |
| Daniell Richard | Derivatives Exercise | 17,295 | 2026-03-09 | ||
| Jover Placid | Sale | -14,150 | $31.67 | $448,108 | 2026-03-09 |
| Jover Placid | Derivatives Exercise | 14,150 | 2026-03-09 | ||
| Savage Brian | Sale | -1,127 | $31.67 | $35,690 | 2026-03-09 |
| Savage Brian | Derivatives Exercise | 3,580 | 2026-03-09 | ||
| Shields Matthew | Sale | -17,295 | $31.67 | $547,705 | 2026-03-09 |
| Shields Matthew | Derivatives Exercise | 17,295 | 2026-03-09 | ||
| Francis Richard D | Sale | -23,393 | $32.46 | $759,442 | 2026-03-06 |
| Francis Richard D | Derivatives Exercise | 50,223 | 2026-03-06 | ||
| Daniell Richard | Sale | -91,345 | $32.46 | $2,965,470 | 2026-03-06 |
| Daniell Richard | Derivatives Exercise | 53,973 | 2026-03-06 | ||
| Sabag Mark | Derivatives Exercise | 52,113 | 2026-03-06 | ||
| Hughes Eric A | Sale | -11,277 | $32.46 | $366,102 | 2026-03-06 |
| Hughes Eric A | Derivatives Exercise | 23,251 | 2026-03-06 | ||
| Kalif Eliyahu Sharon | Derivatives Exercise | 56,763 | 2026-03-06 | ||
| MIGNONE ROBERTO | Sale | -77,400 | $30.24 | $2,340,646 | 2025-12-18 |
| Weiss Amir | Sale | -12,300 | $30.2 | $371,504 | 2025-12-18 |
| Sabag Mark | Sale | -216,892 | $28.75 | $6,235,211 | 2025-12-11 |
| Sabag Mark | Derivatives Exercise | 118,724 | 2025-12-11 | ||
| Daniell Richard | Sale | -115,468 | $28.68 | $3,311,126 | 2025-12-11 |
| Daniell Richard | Derivatives Exercise | 115,468 | 2025-12-11 | ||
| Lichtenstein Chen | Derivatives Exercise | 4,804 | 2025-12-04 | ||
| MIGNONE ROBERTO | Sale | -50,000 | $26.03 | $1,301,505 | 2025-12-01 |
| Fox Christine | Sale | -28,229 | $24.78 | $699,523 | 2025-11-24 |
| Fox Christine | Derivatives Exercise | 63,492 | 2025-11-24 | ||
| Fox Christine | Sale | -30,000 | $25.11 | $753,321 | 2025-11-18 |
| MIGNONE ROBERTO | Sale | -200,000 | $24.11 | $4,821,880 | 2025-11-10 |
| Weiss Amir | Sale | -12,300 | $24.44 | $300,564 | 2025-11-10 |
The information provided in this report about TEVA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Teva Pharmaceutical Industries Limited(NYSE:TEVA) 
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, ...
Website: http://www.tevapharm.com
Founded: 1944
Full Time Employees: 40,039
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic